KaloBios Pharmaceuticals' Debt Round

KaloBios Pharmaceuticals raised a round of funding on September 06, 2012. Investors include MidCap Financial.

KaloBios Pharmaceuticals, a pharmaceutical company, is developing a portfolio of patient-targeted, first-in-class monoclonal antibodies (mAbs) designed to significantly improve the lives of seriously …

Articles about KaloBios Pharmaceuticals' Debt Round: